<?xml version="1.0" encoding="UTF-8"?>
<ref id="R60">
 <label>60.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Choopanya</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Suntharasamai</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Sangkum</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Mock</surname>
    <given-names>PA</given-names>
   </name>
   <name>
    <surname>Leethochawalit</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial</article-title>. 
  <source>
   <italic>Lancet</italic>
  </source>
  <year>2013</year>; 
  <volume>381</volume>:
  <fpage>2083</fpage>â€“
  <lpage>2090</lpage>. 
  <comment>doi: 10.1016/S0140-6736(13)61127-7</comment>.
  <pub-id pub-id-type="pmid">23769234</pub-id>
 </mixed-citation>
</ref>
